Resumen de: WO2025232122A1
The present disclosure relates to the technical field of water body denitrification and ecological restoration. Disclosed are a system and method for purifying a water body by means of coupled denitrification with plants, bacteria and algae. The system comprises a water intake pipe (1), a microalgae growth tank (2), an algae-bacteria solution tank (6), an influent plant tank (8), a main reaction tank and an effluent tank (14) which are sequentially connected, wherein the influent plant tank (8), the main reaction tank and the effluent tank (14) are each independently equipped with plants (9) containing denitrifying bacteria; the main reaction tank comprises a deoxygenation tank (10), a facultative anaerobic tank (11) and an anoxic tank (12) which are sequentially connected; and the main reaction tank is further provided with a bacteria solution return pipe (13), and the bacteria solution return pipe (13) is connected to an inlet of the algae-bacteria solution tank (6). In the system and method, a carbon source can be naturally and continuously supplied; and the system and method operate with stability and high reliability, and has strong resistance to shock loads.
Resumen de: WO2025233717A1
An algae-based air pollution reduction mechanism integrated into a building façade comprises photobioreactor panels (20) containing microalgae to absorb carbon dioxide (CO2), produce biomass, and release oxygen (O2). An air suction mechanism (10) captures polluted air and directs it to a central laboratory (50), where CO2 is separated and supplied to the panels. A gray water collection system stores and mixes gray water with algal powder for the panels. A panel rotation mechanism (40) optimizes solar absorption, while a degassing unit extracts and releases O2. Sensors monitor pollution levels, activating the air suction mechanism (10) when pollutants exceed a threshold, facilitating CO2 conversion into biomass and O2 through the photobioreactor panels (20).
Resumen de: US2025340806A1
There are closed systems of growing microalgae but as they are not able to produce algal biomass economically they are very few and far between and are only used to grow microalgae for very expensive produce. These closed systems also require large space. The result of the lack of economic closed systems is why almost all algal biomass production currently uses raceway ponds. This invention integrates a new compact. very economic and highly productive closed system of growing microalgae including good parameter control with carbon sequestration from say a coal fired power plant or organic waste management in a way that makes the whole process financially attractive and cyclic and if desired it could be made carbon negative. The compact nature of this invention allows algal farms to be sited next to most sources of carbon dioxide.
Resumen de: US2025339483A1
Provided are compositions containing microalgae extracellular vesicles (MEVs) formulated for intranasal delivery, whereby, upon intranasal administration the MEVs traffic through specific routes following intranasal administration to specific regions in the brain via the olfactory nerve and throughout the lateral olfactory tract (LOT) to interconnected brain regions. The MEVs traffic via neuronal axonal transport. The MEVs have the ability to cross-over synapses including: (i) the synapses between the olfactory sensory neurons (OSN) and the mitral/tufted neurons; (ii) the synapses between the mitral/tufted neurons and the local neurons in the various brain regions colonized by the lateral olfactory tract (LOT); and (iii) the synapses between the neurons in the brain regions colonized by the LOT and neurons from the frontal cortex, the hippocampus, the thalamus, and the hypothalamus. The compositions contain extracellular vesicles from microalgae (MEVs) that are loaded with bioactive cargo for treating, detecting, diagnosing, or monitoring a disease, disorder, or condition of the brain or involving the brain, particularly providing neuronal delivery of the cargo. The compositions and methods have a variety of applications as therapeutics and diagnostics for treating, diagnosing, and monitoring a disease, disorder, or condition of the brain or involving the brain. The compositions can be used in methods and uses for treating cancers involving the brain, and can be used, for exa
Resumen de: WO2025227212A1
The invention relates to a structure and method for air purification and addresses a need in the field of sustainability, providing a sustainable alternative for improving air quality with emphasis on the capture of CO2 and carbon monoxide using aquatic organisms, microalgae, and cyanobacteria.
Resumen de: WO2025227221A1
Photobioreactors are described herein. The photobioreactors include a vessel for cultivating microalgae. The vessel defines an interior chamber comprising a culture containing medium. The vessel has at least one transparent wall to permit passage of light of a frequency necessary to promote growth of the microalgae in the culture containing medium. The vessel also includes a plurality of sensors, each sensor being configured to monitor at least one environmental condition within the photobioreactor, and at least one flow generator positioned within the vessel. The photobioreactor also includes a controller communicatively coupled to each of the plurality of sensors and the at least one flow generator. The controller is configured to: receive sensor data from each of the plurality of sensors, apply a mathematical model to the sensor data to determine when to adjust at least one environmental condition within the photobioreactor and adjust one or more components of the photobioreactor.
Resumen de: AU2023416213A1
Provided herein are methods for cultivated food production involving the use of microalgae. The methods include recycling spent cell media that are used to cultivate cells for cultivated food production as well as enriching culture medium used to cultivate the same cells. The microalgae are used to recycle the spent culture medium. The microalgae may be used to extract microalgae derived components to enrich the culture medium. The algae recycling and algae enriched growth media as provided herein may be used with any animal cell culture. In some variations, the microalgae or microalgae derived components may be used as a raw ingredient in the preparation of cell based seafood products. The methods provided herein may be used for the production of seafood products. The methods herein may provide at least one added advantage—the use of algae may add nutrients, flavors, and aromas typically desired in seafood.
Resumen de: WO2025224659A1
The present disclosure relates to an apparatus for microalgae and/or cyanobacteria cell culture comprising a unitary body formed from a hydrophobic material; and two or more microcapillary channels extending along the unitary body; wherein the inner surface of the microcapillary channels is coated with nutrients suitable for microalgae and/or cyanobacteria cell culture; and wherein the hydrophobic material is transparent to visible light, and to a kit and sensor thereof. A method for culturing microalgae and/or cyanobacteria in an apparatus comprising a unitary body formed from a hydrophobic material and two or more microcapillary channels extending along the unitary body, wherein the hydrophobic material is transparent to visible light is also disclosed.
Resumen de: WO2024133379A1
The invention relates to a method for preparing a cyanobacterium extract, preferably spirulina, comprising phycocyanin enriched in trace elements. The invention also relates to an extract obtained by the method according to the invention, to a composition comprising said extract and to the use thereof.
Resumen de: WO2024132882A1
The invention provides marine microalgal strain of the Ulvales order of the Ulvophyceae class which have utility in the efficient and environmentally beneficial preparation of triacylglycerides and polyunsaturated fatty acids, which can in turn be used for fuels or feeds.
Resumen de: US2025325609A1
Provided is a composition comprising microalgae and clay, formulated for ingestion, application to skin, an oral cavity, or administration rectally to a mammal. Also provided is a method of treating a mammal. The method comprises administering the above composition to the mammal.
Resumen de: WO2025221466A1
The invention relates to a method of producing a phototrophic cyanobacteria based biofertilizer.
Resumen de: US2025327096A1
A method for enhancing growth of a microalgal species and its biomass production yield by co-cultivating the microalgal species with a bacterial isolate under the genus of Pseudoalteromonas in separate compartments. The microalgal species is selected from Dunaliella species. The genome sequence of the Pseudoalteromonas isolate can have a nucleotide similarity of lower than 95% to that of other Pseudoalteromonas species.
Resumen de: FI20255068A1
The present approach describes continuous, steady state algal aquaculture systems, methods, and uses. Algal aquaculture systems may employ an algal aquaculture zone to grow the microalga of interest, and a collector for receiving a continuous stream of algal aquaculture medium for fracking and harvesting.
Resumen de: FI20255069A1
The present approach describes continuous, steady state algal aquaculture systems, methods, and uses. Algal aquaculture systems may employ a plurality of algal aquaculture stages, first to grow the microalga of interest, and subsequent stages for subjecting the microalga of interest to controlled stress. Algae biomass composition in the last algal aquaculture stage can be selectively determined through various process elements to impact product generation and/or to reduce the recalcitrance of the algal biomass towards downstream processing, such as fracking the cells to enable chemical-free harvesting via, e.g., adsorptive bubble technology.
Resumen de: WO2025217267A1
Methods for the fermentative production of O-phosphoserine, cysteate, or taurine in microbes or unicellular organisms that contain a serB mutation that either decreases serB expression, reduces the amount of the serB gene product or results in a serB gene product with low enzymatic activity. Genetic modifications of the O-phosphoserine, cysteate, or taurine and/or substrate biosynthetic pathways in unicellular organisms that include bacteria, algae, microalgae, diatoms, yeast, or fungi are disclosed. Also disclosed are fermentation and processing methods for the production of various O-phosphoserine-, cysteate-, or taurine-containing products and the use of the cells, fermentation broth or extracts that contain O-phosphoserine, cysteate, or taurine to produce products for use in food, feed, beverages, dietary and health supplements, cosmetics, personal care, pharmaceuticals, agricultural production, or surfactants.
Resumen de: US2025319145A1
The present invention relates to an anti-inflammatory extract of soil microorganisms or a fraction thereof, wherein the microorganisms comprise one or more selected from Chlorophyta, Xanthophyceae or Cyanobacteria. The invention further relates to compositions comprising two or more of Lyso-DGTS, p-Coumaric acid (ester-linked), oleamide, theophylline, or DGTS. The invention further relates to pharmaceutical compositions comprising the anti-inflammatory extract of soil microorganisms or a fraction thereof or a composition comprising two or more of Lyso-DGTS, p-Coumaric acid (ester-linked), oleamide, theophylline, or DGTS as an active ingredient. The invention further relates to an anti-inflammatory extract of soil microorganisms or a fraction thereof or a pharmaceutical composition comprising an anti-inflammatory extract of soil microorganisms or a fraction thereof or a composition comprising two or more of Lyso-DGTS, p-Coumaric acid (ester-linked), oleamide, theophylline, or DGTS as an active ingredient for use as a medicament, wherein the microorganisms comprise one or more selected from Chlorophyta, Xanthophyceae or Cyanobacteria. The invention further relates to compositions comprising an anti-inflammatory extract of soil microorganisms or a fraction thereof, wherein the microorganisms comprise one or more selected from Chlorophyta, Xanthophyceae or Cyanobacteria.
Resumen de: AU2025238093A1
A biofertiliser composition comprising a living microalgae component consisting of a live microalga of Chlorella spp. and a live microalga of Anabaena spp., wherein the ratio of Chlorella spp. to Anabaena spp. is from 1.0:0.8 to 1.0:1.2. ep b i o f e r t i l i s e r c o m p o s i t i o n c o m p r i s i n g a l i v i n g m i c r o a l g a e c o m p o n e n t c o n s i s t i n g o f a e p l i v e m i c r o a l g a o f h l o r e l l a s p p a n d a l i v e m i c r o a l g a o f n a b a e n a s p p , w h e r e i n t h e r a t i o o f h l o r e l l a s p p t o n a b a e n a s p p i s f r o m : t o :
Resumen de: AU2024242961A1
Provided is a method for producing ammonia comprising: preparing a modified cyanobacterium in which the proportion of heterocysts in cells constituting a nitrogen-fixing cyanobacterium is increased; and irradiating a mixture containing the modified cyanobacterium, a photocatalyst, and water with light in the presence of nitrogen.
Resumen de: WO2025210558A1
The present invention relates to a process for isolating Extracellular Vesicles (EV) secreted by microalgae (MEV - microalgae extracellular vesicle) cultured in basal and stress environment conditions namely pH, salinity, light, nutrient starvation, and temperature. Additionally, microalgae can be cultivated in thermal water classified as bicarbonate, sulphate, sulphide, chloride, or weakly mineralized trace metal. The present invention also relates to compositions comprising said MEV, which are useful to be applied to therapeutic, cosmetic, nutraceutical, phytopharmaceutical and medical including veterinary applications. The present invention lays in the technical domain of pharmaceuticals, medicine, cosmetics, nutraceutical, veterinary and research and development in cellular biology and appliances thereof.
Resumen de: GB2640110A
The present invention relates to the technical field of aquaculture effluent treatment, in particular to an apparatus for microalgae-microorganism synergistic treatment of aquaculture effluent. The apparatus comprises an aquaculture part; the aquaculture part is in communication with an effluent discharge part; the effluent discharge part is in communication with an effluent treatment part; and the effluent treatment part is in communication with the aquaculture part. The effluent discharge part comprises an effluent discharge pipe in communication with the aquaculture part; the end of the effluent discharge pipe away from the aquaculture part is in communication with the effluent treatment part; and an effluent discharge pump is arranged on the effluent discharge pipe. The effluent treatment part comprises a second housing; the bottom end of the second housing is in communication with the effluent discharge pipe; the top end of a side wall of the second housing is in communication with the aquaculture part; the interior of the second housing is provided with a plurality of flow guide plates; and microalgae are inoculated on outer side walls of the flow guide plates. In the present invention, microalgae and original microorganisms in aquaculture effluent form microalgae-microorganism symbionts, which can reduce carbon, reduce nitrogen and remove phosphorus synchronously and have few effects on aquaculture organisms, so that the quality of discharged water can be greatly impro
Resumen de: ES3037626A1
Antibiofouling polymeric materials for the construction of photobioreactors. The present invention discloses a transparent polymeric material comprising silica aerogel particles. These particles provide the material with hydrophobicity, which gives it antibiofouling properties, making it suitable for the construction of photobioreactors for microalgae cultivation. (Machine-translation by Google Translate, not legally binding)
Resumen de: WO2025206966A1
The present invention refers to a biotechnological process for obtaining suspensions of biogenic nanoparticles of zerovalent selenium, which have a high stability, and which have agronomic functions specific to plant biostimulants, that are amplified as a result of the formation of a biocorona which includes bioactive molecules from the biotechnological system wherein these selenium nanoparticles were formed. The biotechnological process involves the biosynthesis of selenium nanoparticles by the consortium of microalgae, Nannochloris sp. 424-1, deposited under CCAP number 251/10 in the Culture Collection of Algae and Protozoa (CCAP), and yeasts, Rhodotorula mucilaginosa TazRr, deposited under DSM number 34804, at the Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures, to promote the formation of suspensions of stable selenium nanoparticles. The process also includes separation and concentration steps by micro- and ultrafiltration on ceramic membranes.
Resumen de: WO2024105258A1
The invention relates to a method for the preparation of microalgal for use as a food-grade ingredient without the need of any further purification or separation step and resulting products therefrom.
Nº publicación: EP4620529A2 24/09/2025
Solicitante:
PHILIP MORRIS PRODUCTS SA [CH]
Philip Morris Products, S.A
Resumen de: EP4620529A2
A composition comprising a eukaryotic microalgae or an extract thereof may be for use in the treatment of a viral disease, e.g. coronavirus, and for use as an inhibitor of the binding of Spike protein receptor binding domain (RBD) to Angiotensin-Converting Enzyme 2 (ACE2). A compound derivable from eukaryotic microalgae may also be for use in the treatment of a viral disease. In turn, a eukaryotic microalgae may be used as an antiviral agent.